Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

October 2023; Volume 43,Issue 10

Letter to the Editor

  • Open Access
    From Mendel to Gene Therapy
    SAMANTHA L. JEFFREY, DON A. BRIGHAM, SANT P. CHAWLA, NOAH FEDERMAN, FREDERICK L. HALL and ERLINDA M. GORDON
    Anticancer Research October 2023, 43 (10) 4257-4261; DOI: https://doi.org/10.21873/anticanres.16620

Reviews

  • Open Access
    The Influence of Statin Use on Chemotherapeutic Efficacy in Studies of Mouse Models: A Systematic Review
    ANGELA TULK, RAJ WATSON and JENNIFER ERDRICH
    Anticancer Research October 2023, 43 (10) 4263-4275; DOI: https://doi.org/10.21873/anticanres.16621
  • Open Access
    High Clinical Concordance of Drug Resistance in Patient-derived Orthotopic Xenograft (PDOX) Mouse Models: First Step to Validated Precise Individualized Cancer Chemotherapy
    TAKASHI HIGUCHI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, SHINJI MIWA, KENTARO IGARASHI, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN
    Anticancer Research October 2023, 43 (10) 4277-4284; DOI: https://doi.org/10.21873/anticanres.16622
  • Open Access
    Surgery for Hepatocellular Carcinoma With Macroscopic Vascular Invasion in the Era of Modern Molecular Therapy
    KENSUKE YAMAMURA, TORU BEPPU, TATSUNORI MIYATA, KOSUKE MIMA, HIROHISA OKABE, HIDETOSHI NITTA, KATSUNORI IMAI, HIROMITSU HAYASHI, ERI ODA, RYUICHI KARASHIMA, NOBUYUKI OZAKI and TAKATOSHI ISIKO
    Anticancer Research October 2023, 43 (10) 4285-4293; DOI: https://doi.org/10.21873/anticanres.16623
  • Open Access
    Biology and Management of Deep-seated Atypical Lipomatous Tumor of the Extremities
    JUN NISHIO, SHIZUHIDE NAKAYAMA, YOSHIRO CHIJIIWA and MIKIKO AOKI
    Anticancer Research October 2023, 43 (10) 4295-4301; DOI: https://doi.org/10.21873/anticanres.16624
  • Open Access
    Prognostic Value of HER2-low Status in ER+ Early Breast Cancer: A Systematic Review and Meta-Analysis
    FAUSTO PETRELLI, CARMEN REA, MARIA CHIARA PARATI, KAREN BORGONOVO, MARA GHILARDI, LORENZO DOTTORINI, ANDREA LUCIANI, MICHELE GHIDINI, FIORELLA RUATTA, ORNELLA GARRONE and GIANLUCA TOMASELLO
    Anticancer Research October 2023, 43 (10) 4303-4313; DOI: https://doi.org/10.21873/anticanres.16625
  • Open Access
    Vascular Endothelial Growth Factor Family and Head and Neck Squamous Cell Carcinoma
    CRISTINA-STEFANIA DUMITRU and MARIUS RAICA
    Anticancer Research October 2023, 43 (10) 4315-4326; DOI: https://doi.org/10.21873/anticanres.16626
  • Open Access
    Circulating Tumor Cells and Tumor Progression, Metastasis, and Poor Prognosis in Patients With Neuroblastoma
    MASATO KOJIMA and EISO HIYAMA
    Anticancer Research October 2023, 43 (10) 4327-4331; DOI: https://doi.org/10.21873/anticanres.16627

Experimental Studies

  • Open Access
    Oleuropein Induces Cytotoxicity and Peroxiredoxin Over-expression in MCF-7 Human Breast Cancer Cells
    KATHERINE JUNKINS, MARGARET RODGERS and SHELLEY A. PHELAN
    Anticancer Research October 2023, 43 (10) 4333-4339; DOI: https://doi.org/10.21873/anticanres.16628
  • Open Access
    Cetuximab Enhances the Efficacy of MRTX1133, a Novel KRASG12D Inhibitor, in Colorectal Cancer Treatment
    MASAHIRO KATAOKA, MASATO KITAZAWA, SATOSHI NAKAMURA, MAKOTO KOYAMA, YUTA YAMAMOTO, SATORU MIYAZAKI, NAO HONDO, HIROKAZU TANAKA and YUJI SOEJIMA
    Anticancer Research October 2023, 43 (10) 4341-4348; DOI: https://doi.org/10.21873/anticanres.16629
  • Open Access
    Molecular Characteristics of Everolimus-resistant Renal Cell Carcinoma Cells Generated by Continuous Exposure to Everolimus
    YUKO NAKAYAMA, DAICHI ENOMOTO, KAZUHIRO YAMAMOTO and KOHJI TAKARA
    Anticancer Research October 2023, 43 (10) 4349-4357; DOI: https://doi.org/10.21873/anticanres.16630
  • Open Access
    Impact of SMAD2 and MET Expression on Lymph Node Metastasis of HER2-positive Gastric Cancer Cells
    GEN TSUJIO, MASAKAZU YASHIRO, TAKASHI SAKUMA, RIKA AOYAMA, KOJI MARUO, YURIE YAMAMOTO and KIYOSHI MAEDA
    Anticancer Research October 2023, 43 (10) 4359-4364; DOI: https://doi.org/10.21873/anticanres.16631
  • Open Access
    PD-L1 mRNA Detection in Immunohistochemically Negative Patients: A Complementary Method for a Better Treatment Selection?
    ULRICH SOMMER, MARIANNE GROSSER, DANIELA AUST, KORINNA JOEHRENS, KATHARINA BOEHM, CHRISTIAN THOMAS, PIA HOENSCHEID, HOLGER H.H. ERB and GUSTAVO B. BARETTON
    Anticancer Research October 2023, 43 (10) 4365-4371; DOI: https://doi.org/10.21873/anticanres.16632
  • You have access
    Development of Polyethylene Glycol-based Hydrogels Optimized for In Vitro 3D Culture of HepG2 Hepatocarcinoma Cells
    YOUNG JAE LEE, KEUN CHEON KIM, JEONG MIN LEE, JEONG MOOK LIM and SEUNG TAE LEE
    Anticancer Research October 2023, 43 (10) 4373-4377; DOI: https://doi.org/10.21873/anticanres.16633
  • You have access
    miR-122-5p Restrains Pancreatic Cancer Cell Growth and Causes Apoptosis by Negatively Regulating ASCT2
    PING REN, NA WU, SHICHEN FU, WENBIN WANG, QI LI and QINGZHOU CHENG
    Anticancer Research October 2023, 43 (10) 4379-4388; DOI: https://doi.org/10.21873/anticanres.16634
  • You have access
    Targeting SALL4 by Entinostat Inhibits the Malignant Phenotype of Gastric Cancer Cells by Reducing EMT Signaling
    LINLIN DU, FEI XIE, HAIBO HAN and LIANHAI ZHANG
    Anticancer Research October 2023, 43 (10) 4389-4401; DOI: https://doi.org/10.21873/anticanres.16635
  • You have access
    Unlocking Synergistic Potential: Enhancing Regorafenib Efficacy in Hepatocellular Carcinoma Through Combination Therapy With 18β-Glycyrrhetinic Acid
    JR-DI YANG, PO-FU YUEH, TSAI LAN LIAO, YING-TZU CHEN, FEI-TING HSU, I-TSANG CHIANG, CHING MING CHANG and WEI-SHU WANG
    Anticancer Research October 2023, 43 (10) 4403-4412; DOI: https://doi.org/10.21873/anticanres.16636
  • You have access
    Melatonin Inhibits Gastric Cancer Cell Proliferation by Suppressing Exosome miR-27b-3p Expression
    YI-QIANG ZHANG, SHUAI-SHUAI SHI, YUN-FEI LI, YANG YANG, PENG BAI and CHU-HAN QIAO
    Anticancer Research October 2023, 43 (10) 4413-4424; DOI: https://doi.org/10.21873/anticanres.16637
  • You have access
    The Effect of Respiratory Motion in Breast Intensity-modulated Radiation Therapy: 3D-Printed Dynamic Phantom Study
    YOUNG EUN CHOI, KIHOON SUNG, KAP SANG DONG, HAN-BACK SHIN, HYUN JU KIM and YOUNG-KHI LIM
    Anticancer Research October 2023, 43 (10) 4425-4433; DOI: https://doi.org/10.21873/anticanres.16638
  • You have access
    High-throughput Sequencing Analysis of Differentially Expressed microRNAs Associated With SREBP1 in Differentiated Thyroid Carcinoma
    JIATING ZHOU, JIANQIU LIU, KE ZHANG, JING LV, XIAOWEI PENG, JIE LIU and ZHI LI
    Anticancer Research October 2023, 43 (10) 4435-4446; DOI: https://doi.org/10.21873/anticanres.16639
  • Open Access
    Estrogen Effects Differ Between Medium Maintenance and Replacement from Transcriptional and Clinical Perspectives in T47D Breast Cancer Cells
    SEOK-HOON JANG, SE HYUN PAEK, JONG-KYU KIM, JE KYUNG SEONG and WOOSUNG LIM
    Anticancer Research October 2023, 43 (10) 4447-4469; DOI: https://doi.org/10.21873/anticanres.16640
  • You have access
    Vitamin C Improves the Inhibitory Effects of Oxaliplatin on HCT-116 Colorectal Cancer Growth and Progression Through Cellular Oxidant Function-associated Cadherin Molecules
    PORNNAPAT CHUSANGNIN, THARATHIP MUANGTHONG, WITCHUDA PAYUHAKRIT, SARAWOOT PALIPOCH and PRASIT SUWANNALERT
    Anticancer Research October 2023, 43 (10) 4461-4472; DOI: https://doi.org/10.21873/anticanres.16641
  • You have access
    Immune Cell Infiltration and Clinical Significance of Angiogenesis-related Genes in Lung Adenocarcinoma
    QI ZHAO, WEIXING REN, SHUPING GAO and NAN MU
    Anticancer Research October 2023, 43 (10) 4473-4489; DOI: https://doi.org/10.21873/anticanres.16642
  • You have access
    Comprehensive Analysis of KREMEN2 as an Immunotherapeutic and Prognostic Biomarker in Pan-Cancer
    JIN LIU, BIN ZHU, JIADI CHEN and YINGPING CAO
    Anticancer Research October 2023, 43 (10) 4491-4509; DOI: https://doi.org/10.21873/anticanres.16643

Clinical Studies

  • Open Access
    The Integrated i31-GEP Test Outperforms the MSKCC Nomogram at Predicting SLN Status in Melanoma Patients
    MICHAEL TASSAVOR, BRIAN J. MARTIN and ALEX M. GLAZER
    Anticancer Research October 2023, 43 (10) 4511-4516; DOI: https://doi.org/10.21873/anticanres.16644
  • Open Access
    Clinicopathological Characteristics, Survival Outcomes, and Prognostic Factors in Adult Patients With Sinonasal Rhabdomyosarcoma: Insights from a Retrospective Cohort Study
    MONIKA DURZYNSKA, FLORENTINO LUCIANO CAETANO DOS SANTOS and IRMINA MARIA MICHALEK
    Anticancer Research October 2023, 43 (10) 4517-4524; DOI: https://doi.org/10.21873/anticanres.16645
  • Open Access
    Threshold Optimization for Tumor Markers S100b and MIA in Uveal Melanoma – A Single Center Analysis
    NAEMI GLASER, ANNE PETZOLD, ANJA WESSELY, MATTHIAS D. KAUFMANN, ELIAS A.T. KOCH, HARALD KNORR, CAROLINE VOSKENS, MARKUS V. HEPPT, CAROLA BERKING and MICHAEL ERDMANN
    Anticancer Research October 2023, 43 (10) 4525-4532; DOI: https://doi.org/10.21873/anticanres.16646
  • Open Access
    Serum Creatinine Elevation as a Risk Factor for Niraparib-induced Hematologic Toxicity
    KOKI HASHIMOTO, KAZUYOSHI KAWAKAMI, TAKASHI YOKOKAWA, NAOKI SHIBATA, AZUSA SOEJIMA, TAKAHITO SUGISAKI, YUKA MORI, HISANORI SHIMIZU, MAYU YUNOKAWA, HIROYUKI KANAO and MASAKAZU YAMAGUCHI
    Anticancer Research October 2023, 43 (10) 4533-4541; DOI: https://doi.org/10.21873/anticanres.16647
  • Open Access
    Outcomes of 30 Gy/5 Fr Hypofractionated Stereotactic Radiation Therapy for Small Brain Metastases (≤2 cm)
    YOSHIHIRO KAWAI, SHUHEI ARAMAKI, TOMOSHIGE ISHIHARA, KOSUKE SUZUKI, TSUYOSHI OKAWA, ERIKO SATO, NAOFUMI OTA, TAKASHI KOSUGI, MORIKAZU AMANO and KENTA KONISHI
    Anticancer Research October 2023, 43 (10) 4543-4549; DOI: https://doi.org/10.21873/anticanres.16648
  • You have access
    Prognostic Implications of PRAME Expression and Clinicopathological Factors in Sinonasal Mucosal Melanoma: A Single-center Cohort Study of 30 Cases
    MONIKA DURZYNSKA, FLORENTINO LUCIANO CAETANO DOS SANTOS, ALDONA MATUSZCZYK, EDYTA DEREZINSKA-WOLEK and IRMINA MARIA MICHALEK
    Anticancer Research October 2023, 43 (10) 4551-4557; DOI: https://doi.org/10.21873/anticanres.16649
  • Open Access
    Mesonephric-like Adenocarcinoma of the Uterine Corpus: Clinicopathological and Prognostic Significance of L1 Cell Adhesion Molecule (L1CAM) Over-expression
    SUHO PARK, YUNJOO CHO and HYUN-SOO KIM
    Anticancer Research October 2023, 43 (10) 4559-4571; DOI: https://doi.org/10.21873/anticanres.16650
  • Open Access
    Initial-to-nadir Prostate-specific Antigen Ratio Predicts Response to First-line Enzalutamide in Metastatic Castration-resistant Prostate Cancer
    YUJIRO NAGATA, KAZUMASA JOJIMA, TAKUO MATSUKAWA, IKKO TOMISAKI and NAOHIRO FUJIMOTO
    Anticancer Research October 2023, 43 (10) 4573-4581; DOI: https://doi.org/10.21873/anticanres.16651
  • You have access
    Atezolizumab for EGFR-mutated Non-small Cell Lung Cancer Patients: An Observation Study in Ibaraki Group (ATTENTION-IBARAKI)
    TOMOHIRO TAMURA, TAKESHI NUMATA, HIDETOSHI YANAI, RYOTA NAKAMURA, TOSHIHIRO SHIOZAWA, HIROKO WATANABE, SHINICHIRO OKAUCHI, NORIHIRO KIKUCHI, KUNIHIKO MIYAZAKI, SHIGEN HAYASHI, TAKAAKI YAMASHITA, KOICHI KURISHIMA, MASAHARU INAGAKI, HIROAKI SATOH, HIROICHI ISHIKAWA, TAKAYUKI KABURAGI, TAKEO ENDO, TORU SAKAMOTO and NOBUYUKI HIZAWA
    Anticancer Research October 2023, 43 (10) 4583-4591; DOI: https://doi.org/10.21873/anticanres.16652
  • You have access
    Interval Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Ovarian Cancer: Report of a Single-center Experience
    CHRYSOULA LIAKOU, ANASTASIOS PANDRAKLAKIS, MARIA-CLELIA LA RUSSA, HILARY TURNBULL, JOAQUIN NIETO, TIMOTHY DUNCAN, ADAM STEARNS and NIKOLAOS BURBOS
    Anticancer Research October 2023, 43 (10) 4593-4599; DOI: https://doi.org/10.21873/anticanres.16653
  • You have access
    Importance of Atezolizumab Plus Bevacizumab Combination Treatment as First-line Therapy for Immunological Changes in Patients With Unresectable Hepatocellular Carcinoma
    KOJIRO KOBAYASHI, HIDENARI NAGAI, TEPPEI MATSUI, TAKAHISA MATSUDA and KOJI HIGAI
    Anticancer Research October 2023, 43 (10) 4601-4609; DOI: https://doi.org/10.21873/anticanres.16654
  • You have access
    The Efficacy and Safety of a Low Relative Dose Intensity of Cabazitaxel in Patients With Metastatic Castration-resistant Prostate Cancer
    FUMIHIKO URABE, DAIGO KOBAYASHI, KOSUKE IWATANI, YU IMAI, HAJIME ONUMA, KOICHI AIKAWA, TAKAFUMI YANAGISAWA, KOJIRO TASHIRO, HIROSHI SASAKI, JUN MIKI, KENTA MIKI and TAKAHIRO KIMURA
    Anticancer Research October 2023, 43 (10) 4611-4617; DOI: https://doi.org/10.21873/anticanres.16655
  • You have access
    Role of Positive Biopsy Core Ratio in Prostate Cancer Patients
    HIROSHI KANO, KOUJI IZUMI, RYUNOSUKE NAKAGAWA, REN TORIUMI, SHUHEI AOYAMA, TAIKI KAMIJIMA, TAKAFUMI SHIMADA, RENATO NAITO, SUGURU KADOMOTO, HIROAKI IWAMOTO, HIROSHI YAEGASHI, SHOHEI KAWAGUCHI, TAKAHIRO NOHARA, KAZUYOSHI SHIGEHARA, YOSHIFUMI KADONO and ATSUSHI MIZOKAMI
    Anticancer Research October 2023, 43 (10) 4619-4626; DOI: https://doi.org/10.21873/anticanres.16656
  • You have access
    Effect of Positive Biopsy Core Rate on Low-dose-rate Brachytherapy Outcomes in Intermediate-risk Prostate Cancer
    YOSHITO KUSUHARA, TOMOYA FUKAWA, TOMOHARU FUKUMORI, YOSHITERU UENO, KEI DAIZUMOTO, YUTARO SASAKI, RYOTARO TOMIDA, YASUYO YAMAMOTO, KUNIHISA YAMAGUCHI, CHISATO TONOISO, AKIKO KUBO, TAKASHI KAWANAKA, SHUNSUKE FURUTANI, HITOSHI IKUSHIMA, HIRO-OMI KANAYAMA and MASAYUKI TAKAHASHI
    Anticancer Research October 2023, 43 (10) 4627-4635; DOI: https://doi.org/10.21873/anticanres.16657
  • You have access
    Correlation Between Colposcopic Patterns and Histological Grade of Vaginal Intraepithelial Neoplasia: A Retrospective Cohort Study
    ERMELINDA MONTI, CRISTINA MARIA MICHELA MATOZZO, GIULIA EMILY CETERA, EUGENIA DI LORETO, GIADA LIBUTTI, VERONICA BOERO, CARLOTTA CAIA, DANIELA ALBERICO and GIUSSY BARBARA
    Anticancer Research October 2023, 43 (10) 4637-4642; DOI: https://doi.org/10.21873/anticanres.16658
  • You have access
    Outcomes of Sentinel Lymph Node Biopsy for Patients With Node-positive Breast Cancer Treated With Neoadjuvant Chemotherapy
    CALOGERO CIPOLLA, SALVATORE VIENI, ELEONORA D’AGATI, NELLO GRASSI, PIETRO GENOVA, GIUSEPPA GRACEFFA, PAOLO VIGNERI, VITTORIO GEBBIA and MARIA ROSARIA VALERIO
    Anticancer Research October 2023, 43 (10) 4643-4649; DOI: https://doi.org/10.21873/anticanres.16659
  • You have access
    Simultaneous vs. Sequential Boost for Adjuvant Breast Radiotherapy
    MARIE C. EGGERT, STEFAN JANSSEN, NATHAN Y. YU and DIRK RADES
    Anticancer Research October 2023, 43 (10) 4651-4655; DOI: https://doi.org/10.21873/anticanres.16660
  • Open Access
    Increased Incidence of Liver Metastases in Colorectal Versus Appendiceal Adenocarcinoma Peritonectomy Patients Despite Equivocal Survival
    CELINE GARRETT, ADAM CRISTAUDO, SHOMA BARAT and DAVID L. MORRIS
    Anticancer Research October 2023, 43 (10) 4657-4662; DOI: https://doi.org/10.21873/anticanres.16661
  • You have access
    RBM17 Expression Is Associated With the Efficacy of ICI Monotherapy in NSCLC With Low PD-L1 Expression
    HIROAKI NAGAMINE, MASAKAZU YASHIRO, NAOKI YOSHIMOTO, MOTOHIRO IZUMI, AKIRA SUGIMOTO, KENJI NAKAHAMA, KOICHI OGAWA, YOSHIYA MATSUMOTO, KENJI SAWA, YOKO TANI, HIROYASU KANEDA, SHIGEKI MITSUOKA, KAZUHIRO YAMADA, TETSUYA WATANABE, KAZUHISA AASAI, KAZUHIRO FUKUMURA, AKILA MAYEDA and TOMOYA KAWAGUCHI
    Anticancer Research October 2023, 43 (10) 4663-4672; DOI: https://doi.org/10.21873/anticanres.16662
  • Open Access
    Clinical Outcomes With Lenvatinib in Patients Previously Treated With Atezolizumab/Bevacizumab for Advanced Hepatocellular Carcinoma
    HISANORI MUTO, TEIJI KUZUYA, NAOTO KAWABE, EIZABURO OHNO, KOHEI FUNASAKA, MITSUO NAGASAKA, YOSHIHITO NAKAGAWA, RYOJI MIYAHARA, TOMOYUKI SHIBATA, SENJU HASHIMOTO, YOSHIAKI KATANO and YOSHIKI HIROOKA
    Anticancer Research October 2023, 43 (10) 4673-4682; DOI: https://doi.org/10.21873/anticanres.16663
  • You have access
    A Novel Filtration Membrane for Clustered Circulating Tumor Cell Extraction: A Prospective Feasibility Study
    NORIYOSHI SAWABATA, KOHEI MORITA, SHIGENOBU TATSUMI, TOMOMI FUJII, TAKESHI NISHIKAWA, TAKESHI KAWAGUCHI, TORU ARAKANE, YOSHIAKI TOMINAGA, HIROKAZU SAKAGUCHI, TARO KOBAYASHI, SHIGETO HONTSU, YOSHIFUMI YAMAMOTO, NOBUHIRO FUJIOKA, NORIKO OUJI-SAGESHIMA, TOSHIHIRO ITO and CHIHO OHBAYASHI
    Anticancer Research October 2023, 43 (10) 4683-4690; DOI: https://doi.org/10.21873/anticanres.16664
  • You have access
    Immunological Responses Associated With Neoadjuvant Therapy in the Tumor Microenvironment of Esophageal Squamous Cell Carcinoma
    YUKA TAKEHARA, TOMOAKI TAMAKI, KOSAKU MIMURA, KATSUHARU SAITO, PRAJWAL NEUPANE, TAKESHI TADA, YOHEI WATANABE, SUGURU HAYASE, ZENICHIRO SAZE, YUYA YOSHIMOTO, HISASHI SATO, KOJI KONO and YOSHIYUKI SUZUKI
    Anticancer Research October 2023, 43 (10) 4691-4700; DOI: https://doi.org/10.21873/anticanres.16665
  • You have access
    Early Phase Persistent Changes in the White Blood Cell Fraction in Patients With Advanced Urothelial Carcinoma Treated With Pembrolizumab: A Multicenter Retrospective Study
    NOBUKI FURUBAYASHI, AKINORI MINATO, TAKAHITO NEGISHI, NAOTAKA SAKAMOTO, YOOHYUN SONG, YOSHIFUMI HORI, TOSHIHISA TOMODA, HIROYUKI MASAOKA, MIRII HARADA, SHINGO TAMURA, HIROKI KOBAYASHI, KAEDE MORIHARA, KENTARO KUROIWA, NARIHITO SEKI, NAOHIRO FUJIMOTO and MOTONOBU NAKAMURA
    Anticancer Research October 2023, 43 (10) 4701-4708; DOI: https://doi.org/10.21873/anticanres.16666
  • You have access
    Impact of Genomic Alterations on the Clinical Outcome of Patients With Hepatitis B-related Hepatocellular Carcinoma Receiving Curative Surgery: A Retrospective Cohort Study
    CHIH-CHI WANG, WEN-LANG FAN, TING-TING LIU, SEE-TONG PANG, JING-HOUNG WANG, CHAO-CHENG HUANG, ENG-YEN HUANG and YEN-HAO CHEN
    Anticancer Research October 2023, 43 (10) 4709-4722; DOI: https://doi.org/10.21873/anticanres.16667
  • You have access
    A Case of Anti-3-hydroxy-3-methylglutaryl-coenzyme A Reductase Myopathy Associated With Advanced Cervical Carcinoma
    ARNAUD SAILLANT, MATHILDE RASCLARD, JEAN-BAPTISTE GAUME, ODILE SOUCHAUD and MATTHIEU BAINAUD
    Anticancer Research October 2023, 43 (10) 4723-4727; DOI: https://doi.org/10.21873/anticanres.16668
  • You have access
    Microsatellite Instability-high Signet Ring Cell Carcinoma of the Colon Treated With Immunotherapy: Report of a Case
    KOTA ARIMA, NORIO UEMURA, KENGO TSUNEYOSHI, HIROSHI FUJITA, HIDEYUKI KUROKI, SHINICHIRO UEMURA, NORIHISA HANADA, HIDEO BABA and YOSHIHIRO KOMOHARA
    Anticancer Research October 2023, 43 (10) 4729-4733; DOI: https://doi.org/10.21873/anticanres.16669
  • You have access
    Effective Use of Bromelain and Acetylcysteine (BromAc®) for Treatment of Perigastric Pseudomyxoma Peritonei: A Case Report
    ELIZABETH SKALKOS, KERRY L. CHEN, RUWANTHI WIJAYAWARDANA and DAVID L. MORRIS
    Anticancer Research October 2023, 43 (10) 4735-4738; DOI: https://doi.org/10.21873/anticanres.16670
  • You have access
    Pediatric Spinal Giant Cell-rich Osteosarcoma: Case Report and Brief Literature Review
    HIDENORI SUZUKI, HIROAKI IKEDA, NORIHIRO NISHIDA, MASAHIRO FUNABA, KAZUHIRO FUJIMOTO, RYUTA IWANAGA and TAKASHI SAKAI
    Anticancer Research October 2023, 43 (10) 4739-4745; DOI: https://doi.org/10.21873/anticanres.16671

Abstracts of the 33rd Annual Meeting of the Italian Society of Uro-Oncology (SIUrO)

  • Open Access
    Abstracts of the 33rd Annual Meeting of the Italian Society of Uro-Oncology (SIUrO)
    Anticancer Research October 2023, 43 (10) 4747-4778; DOI: https://doi.org/10.21873/anticanres.16672

Corrigenda

  • Open Access
    Corrigenda
    Anticancer Research October 2023, 43 (10) 4779; DOI: https://doi.org/10.21873/anticanres.16673

Retraction

  • Open Access
    Retraction
    Anticancer Research October 2023, 43 (10) 4780; DOI: https://doi.org/10.21873/anticanres.16674
Back to top
PreviousNext

In this issue

Anticancer Research: 43 (10)
Anticancer Research
Vol. 43, Issue 10
October 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • High Clinical Concordance of Drug Resistance in Patient-derived Orthotopic Xenograft (PDOX) Mouse Models: First Step to Validated Precise Individualized Cancer Chemotherapy
  • The Influence of Statin Use on Chemotherapeutic Efficacy in Studies of Mouse Models: A Systematic Review
  • Oleuropein Induces Cytotoxicity and Peroxiredoxin Over-expression in MCF-7 Human Breast Cancer Cells
  • Cetuximab Enhances the Efficacy of MRTX1133, a Novel KRASG12D Inhibitor, in Colorectal Cancer Treatment
  • Outcomes of 30 Gy/5 Fr Hypofractionated Stereotactic Radiation Therapy for Small Brain Metastases (≤2 cm)
Sign up for alerts

Jump to

  • Letter to the Editor
  • Reviews
  • Experimental Studies
  • Clinical Studies
  • Abstracts of the 33rd Annual Meeting of the Italian Society of Uro-Oncology (SIUrO)
  • Corrigenda
  • Retraction
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire